The mRNA levels of the B4GAT1 gene have been found to be decreased or undetectable in cell lines derived from prostate cancer, including PC3, PC3-L and LNCaP, and from breast cancer, such as MDA-MB-231 and MDA-MB-435 [105]. Here, B4GAT1 is linked to prostate carcinoma.